Expertise
Vaccines
Accelsiors has played a significant role in the development of both prophylactic and therapeutic vaccines
We understand the immense potential of vaccines in preventing diseases and revolutionizing medical treatments. Over the years, we have been actively engaged in conducting Phase I, II, and III studies for a wide range of vaccines.
Our involvement in vaccine development spans various infectious diseases, including seasonal influenza, rabies, and varicella-zoster. These studies have allowed us to contribute to the advancement of vaccines aimed at preventing and controlling infectious diseases.
Furthermore, Accelsiors has expanded its expertise beyond infectious diseases to explore the development of vaccines for other indications.
Our team has been actively involved in the development of vaccines for neuro-inflammatory disorders, cancer, hepatitis C, and Parkinson’s disease
Through these endeavors, we strive to explore the potential of vaccines in treating and managing these conditions.
By leveraging our experience, knowledge, and global networks, we have been able to support the development of innovative vaccines across a wide range of indications. Our commitment to advancing vaccine research and our deep understanding of the regulatory landscape enable us to design and execute robust clinical trials, ensuring the collection of reliable data.
Accelsiors remains dedicated to driving progress in vaccine development and contributing to the improvement of global health outcomes. Through partnerships and collaborations, we aim to accelerate the development of safe and effective vaccines that have the potential to transform medical treatments for a variety of diseases.
We offer flexible cooperation models:
Clinical Trial Services
Clinical Research Consulting
Functional Service Provider
SPARKS
The Accelsiors' White Papers
Click to download
